Sia Biotec is a spin-off company from the ETH Zurich pioneering a novel half-life extension technology. We are at the forefront of in vivo glycoprotein engineering. Our proprietary platform enables the targeted protein modification with a biodegradable sugar polymer, streamlining the development of next-generation therapeutics

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business
Core competencies